The main difference between release tests and stability-indicating tests is that stability-indicating tests: Response:

Question

Options

• AAre only performed once at the time of release
• BFocus exclusively on the product's appearance
• CProvide information on how the quality of a product changes over time
• DAre not required for regulatory compliance

• A
  5% (2)
• B
  12% (5)
• C
  79% (34)
• D
  5% (2)

Explanation

Stability-indicating tests are specifically designed to detect degradation products and measure how a pharmaceutical product's quality attributes change as it ages - making option C correct. Unlike release tests (which confirm a product meets specifications at the moment of manufacture), stability-indicating tests are run at defined intervals over time to predict shelf life and expiry dating.

Why the distractors are wrong:

• A is the opposite of correct - stability tests are performed repeatedly over time (at 3, 6, 12, 18+ months), while release tests are the one-time snapshot.
• B is wrong because stability-indicating tests assess critical quality attributes like potency, degradation products, pH, and moisture content - not just appearance (though appearance may be one parameter among many).
• D is wrong because stability testing is explicitly required by regulatory bodies such as the FDA and ICH (guideline Q1A) as a condition of product approval and registration.

Memory tip: Think of the word "indicating" - these tests indicate a trend. Release tests say "good now"; stability-indicating tests say "here's what happens over time." If a test can't detect a degradant forming at month 12, it isn't truly stability-indicating.

No community discussion yet for this question.